{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "homologue thereof . In a further embodiment , the modified\n\nprotein comprises an amino acid sequence as defined in SEQ\n\nGenome engineering technologies have enabled system\n\nID NO : 2 or a homologue thereof .\n\natic interrogation of genome function and hold great poten-\n\nIn an embodiment , the modified protein comprising a\n\ntial for gene therapy . The clustered regularly interspaced 25 sequence as defined in SEQ ID NO : 1 or SEQ ID NO : 2 or\n\nshort palindromic repeat ( CRISPR ) associated protein ( Cas )\n\na homologue thereof further comprises one or more muta\n\nsystem enables efficient DNA modification guided by a\n\ntions at R245 , N419 and / or R654 positions .\n\ncomplementary RNA and in the presence of a protospacer\n\nIn an embodiment , the modified protein further comprises\n\nadjacent motif ( PAM ) . However , non - perfect guide - RNA-\n\nmutations at R245 , N419 and R654 positions , preferably the\n\ntarget - DNA matching has been known to occur which can 30 modified protein comprises an amino acid sequence as\n\nresult in modifications at genomic loci other than the\n\ndefined in SEQ ID NO : 3 or a homologue thereof .\n\nintended locus . This off - target activity can limit the broad\n\nIn an embodiment , the modified protein further comprises\n\nmutations R245 , N419 and R654 positions , preferably the\n\napplication of this technology . Accordingly , modified pro\n\nteins for altering the genome of a cell with application in\n\nmodified protein comprises an amino acid sequence as\n\ngenome editing and gene therapy are desired .\n\n35 defined in SEQ ID NO : 4 or a homologue thereof .\n\nIn an embodiment , the mutation is a single amino acid\n\nsubstitution .\n\nSUMMARY OF THE INVENTION\n\nIn an embodiment , the modified protein comprises alanine\n\nIn a first aspect , the invention provides a modified protein .\n\nat the N413 position . In a further embodiment , the modified\n\nPreferably , the modified protein is a Streptococcus aureus 40 protein comprises alanine at the N413 , R245 , N419 and / or", "type": "Document"}}